Climate Change Data

United Orthopedic Corporation

Climate Impact & Sustainability Data (2023)

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:5,804.3026 tCO2e/year
Scope 1 Emissions:292.2174 tCO2e/year
Scope 2 Emissions:4,053.8901 tCO2e/year
Scope 3 Emissions:1458.1951 tCO2e/year
Renewable Energy Share:Null (Solar power generation mentioned but not as a percentage of total energy)
Total Energy Consumption:9,246,250 kWh/year
Water Consumption:31,765 m3/year
Waste Generated:Null (Specific figures for total waste are provided by type but not a total)
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Corporate Governance
  • Environmental Management
  • Social Responsibility
  • Product Quality and Safety
  • Employee Well-being

Environmental Achievements

  • Reduced greenhouse gas emissions by implementing energy-saving projects and solar panel installation (specific figures not clearly stated but mentioned in the report)
  • Increased utilization of recycled water, saving 1,365 cubic meters of tap water in 2023

Social Achievements

  • Maintained a low employee turnover rate (15%) compared to the industry average (17%)
  • Implemented comprehensive employee training and development programs with 5632 trainees and 24069.5 training hours in 2023
  • Provided various employee welfare benefits (approximately NT$600 million invested in 2023)
  • Successfully completed more than 630,000 artificial joint replacement surgeries globally

Governance Achievements

  • Established a Sustainability Development Committee under the Board of Directors and an ESG Promotion Task Force
  • Held seven board meetings in 2023
  • Implemented a comprehensive internal control system and risk management framework
  • No violations of laws and regulations in 2023

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Market competition from larger international companies
  • Maintaining product quality and safety standards
  • Managing risks related to supply chain, regulatory changes, and information security
Mitigation Strategies
  • Investing in new plant projects and implementing a one-stop service production plan
  • Developing niche products tailored to target markets
  • Strengthening direct hospital channels in Europe and the United States
  • Implementing strict quality management systems (ISO 13485)
  • Establishing a comprehensive risk management system with regular reviews and assessments
  • Implementing information security policies and training programs

Supply Chain Management

Supplier Audits: Null (Number or percentage not specified, but audits are mentioned)

Responsible Procurement
  • Supplier selection process based on price, quality, delivery time, and sustainability requirements
  • Regular audits and assessments of suppliers

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: GRI Standards (Core option)

Certifications: ISO 13485, ISO 14001, ISO 45001

Third-party Assurance: Deloitte & Touche (Limited assurance)

UN Sustainable Development Goals

  • Goal 3: Good Health and Well-being
  • Goal 4: Quality Education
  • Goal 5: Gender Equality
  • Goal 7: Affordable and Clean Energy
  • Goal 8: Decent Work and Economic Growth
  • Goal 9: Industry, Innovation and Infrastructure
  • Goal 12: Responsible Consumption and Production
  • Goal 13: Climate Action

The company's initiatives contribute to these goals through various ESG programs and practices

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Taipei Biotech Award International Silver Award
  • Hsinchu Science Park Outstanding Vendor Innovative Product Award
  • Taiwan Excellence Gold Award
  • National Innovation Award